Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We downgraded our recommendation on Range Resources Corporation (RRC - Analyst Report) to Neutral from Outperform on Oct 4, 2013. The company’s strategy of selling its higher cost assets further reduced its overall cost on the one hand, and resulted in reduced yield on the other.

Further, Range Resources remains susceptible to volatile natural gas prices, an imbalance between supply and demand for products, and rising interest rates.Range Resources carries a Zacks Rank #3 (Hold).

Why the Downgrade?

Range Resources’ diversified asset portfolio is spread between low-risk/long reserve-life Appalachian assets and large-volume/rapid-payout Gulf Coast properties.

The company’s focus is on five liquid-rich plays that include the super-rich Marcellus, the super-rich Upper Devonian, the wet Utica, the horizontal Mississippian and the Cline Oil shale play to drive its liquids production. Its primary activity is centered on the super-rich area of southwestern Pennsylvania. Given its dominant position in these plays, especially Marcellus, and its continuous endeavor to control costs, we believe that Range Resources will be capable of long-term shareholder value creation. 

For 2013, Range Resources expects to deliver 20–25% annualized production growth with its focus on liquid-rich opportunities mostly in the Marcellus Shale and Horizontal Mississippian plays that have a combined acreage of about 500,000.

Range Resources has a track record of growing production at a double-digit rate while reducing its finding and development (F&D) costs and sustaining an industry leading low-cost structure. This is due to increased production from the low-cost Marcellus region. Additionally, the sale of higher cost related assets further reduced the company’s overall costs. The company recently disclosed that it aims to sell its acreage in the Permian Basin properties in southeast New Mexico and West Texas. The properties currently produce 18 million cubic feet equivalent million cubic feet equivalent per day of oil and gas.

However, the company’s prospects are closely linked to the successful completion of its growth projects, which in turn, might be affected by operational hindrances, cost inflations and overruns and delays in completion. Further, a failure on the part of management to form beneficial partnerships or dispose low-profit generating assets will likely impair the company’s growth rate and capital expenditure programs.

Other Stocks to Consider

While we prefer to remain on the sidelines forRange Resources, Zacks Ranked #1 (Strong Buy) stocks – China Petroleum & Chemical Corp. (SNP - Analyst Report), Stone Energy Corp. (SGY - Analyst Report) and TransGlobe Energy Corp. (TGA - Snapshot Report) – could be good buying options for the short term.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ANI PHARMACE ANIP 29.38 +14.99%
ATLAS FINANC AFH 14.65 +2.85%
ZIOPHARM ONC ZIOP 3.44 +2.08%
ALLIANCE FIB AFOP 17.66 +1.96%
FEDERATED NA FNHC 20.26 +1.96%